Skip to content

Objective physical activity assessment in patients with moderate to very severe CHF or COPD: a validation study

Objective physical activity assessment in patients with moderate to very severe CHF or COPD: a validation study - Objective physical activity assessment in patients with CHF or COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35065
Enrollment
15
Registered
2010-02-24
Start date
2010-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure chronic obstructive pulmonary disease

Interventions

None listed

Sponsors

Academisch Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: CHF patients: diagnosed with CHF by one of the medical doctors of Ciro COPD: diagnosed with COPD by one of the medical doctors of Ciro Healthy subjects: reported to have no medical problems.

Exclusion criteria

Exclusion criteria: Unable to walk

Design outcomes

Primary

MeasureTime frame
Study A (5 healthy students): -Time spent in weight bearing postures, non-weight bearing postures and movement-related activity assessed by DAAFBtrunk and DAAFBleg compared to a standardized protocol. Study B (5 CHF and 5 COPD patients) -Time spent in weight bearing postures, non-weight bearing postures and movement-related activity assessed by DAAFBtrunk, DAAFBleg and patients* estimation compared to video recordings. Patients will be asked to continue their normal daily activities during the measurements.

Secondary

MeasureTime frame
Study A (5 healthy students): -Subject*s movement intensity (accelerations measured by DAAFBtrunk, DAAFBleg) at five different walking speeds (1.5, 2.5, 3.5, 4.5, 5.5 and 6.5 km/h) on a treadmill. -Date of birth, gender, weight and length

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)